This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2022 Information Coming Soon!

Simone Oostindie
Scientist, Early Stage Translational Research at Genmab

Profile

Simone C. Oostindie is a Scientist in the Early Stage Translational Research Team at Genmab. She joined Genmab in 2014 and specializes in preclinical development of novel antibody therapeutics. Her current work focusses on translational research with respect to antibody biology, novel antibody technology platforms and next-generation antibody therapeutics, as part of her training to obtain her PhD at the Leiden University Medical Center in The Netherlands. She holds an MSc degree in Biology from the University of Wageningen.

Agenda Sessions

  • Exploiting and Understanding Avidity Engineering of Antibodies

    15:45
  • The DuoHexaBody® Platform: Combining Dual Epitope Targeting and Fc Engineering to Boost Antibody Functional Responses

    On Demand